Skip to main content
DHTI
OTC Trade & Services

Dalrada Faces $1.16M Default Claim and Financing Termination from IBS

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$0.009
Mkt Cap
$1.105M
52W Low
$0.002
52W High
$0.099
52W Position info
318% above low
Off High info
91% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

DHTI has more than doubled off its 52-week low of $0.002 on light trading volume (0.1× avg).

Summary

Dalrada's financing partner IBS declared defaults and demanded $1.16M after the company terminated the agreements. Dalrada disputes the claims, arguing IBS never funded the facilities.


Key Events · Legal and Risk Events · DHTI

  • Financing Agreements Terminated

    Genefic terminated its MGA and MCSPA agreements with IBS effective September 15, 2026. IBS never provided any funding under these facilities.

  • IBS Declares Defaults, Demands $1.16M

    IBS asserted events of default and demanded $1,162,246, including $399,214 in 'ledger losses,' $225,000 warrant redemption, and $300,000 in early termination fees.

  • Additional $875K Collateral Demand

    IBS also demanded $875,000 in additional collateral to satisfy a minimum collateral value requirement under the MGA.

  • Company Disputes All Claims

    Dalrada disputes the defaults and amounts, arguing IBS never funded the facilities and the demands consist entirely of fees and internally assessed charges.


Analysis · DHTI · Trade & Services

A financing dispute has escalated into a potential liquidity crisis for Dalrada. Its subsidiary Genefic terminated the financing agreements with IBS, prompting IBS to declare events of default, accelerate the note, and demand $1.16 million in fees, charges, and redemption amounts—plus an additional $875,000 in collateral. The company disputes the defaults, noting that IBS never actually funded the facilities. If unresolved, this dispute could trigger cross-defaults on other debt and further strain Dalrada's already fragile liquidity.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DHTI was trading at $0.01 on OTC in the Trade & Services sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $0.00 to $0.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DHTI - Latest Insights

DHTI
May 21, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.0311
Real-time Price: $0.0092 info
Change: -$0.0219 (-70%) info
Market Cap: $1.105M info
DHTI
May 20, 2026, 7:16 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0311
Real-time Price: $0.0092 info
Change: -$0.0219 (-70%) info
Market Cap: $1.105M info
DHTI
Apr 07, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $0.0421
Real-time Price: $0.0092 info
Change: -$0.0329 (-78%) info
Market Cap: $1.105M info
DHTI
Apr 02, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $0.0421
Real-time Price: $0.0092 info
Change: -$0.0329 (-78%) info
Market Cap: $1.105M info